It's JPM 2025 and here at Fierce Biotech we’re bringing you all the latest updates live from the life sciences event of the ...

The classification of drugs have been around since 1964 after Sir James Black discovered how they can assist people with heart disease.

Scientists Discover New Receptor for Nerve Growth Factor--a Promising Target for Treating Pain Dec. 5, 2024 — Researchers have found a new receptor for nerve growth factor that plays an ...

In an interview with ChosunBiz at Vivozon’s office in Seoul on Jan. 7, Vivozon Chairman Lee Doo-hyun said, “Unafra is the ...

A novel topical gel, HT-001, has shown potential as a treatment for cutaneous side effects from epidermal growth factor ...

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...

Discover if Delta 8 Gummies can help with nausea. Explore the benefits, and best ways to take them, and find out where to buy ...

In patients with cancer, HT-001, designed to address skin toxicities, elicited encouraging interim safety and efficacy ...

Depression is a highly prevalent disorder, and researchers still have a lot to learn about its biological underpinnings.

Studies shed light on pain perception, placebo effect pathways, and how human stem cells can be used to model pain.

Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...

Mirikizumab is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to the p19 subunit of human interleukin (IL)-23.